editor
part
cohort
studi
patient
sever
acut
respiratori
syndrom
sar
beij
china
conduct
followup
studi
patient
routin
medic
examin
process
patient
chest
radiograph
consist
activ
diseas
identifi
pulmonari
tuberculosi
tb
describ
clinic
outcom
immun
respons
patient
demograph
detail
coexist
condit
shown
tabl
patient
healthcar
worker
becam
infect
sarsassoci
coronaviru
cov
duti
sar
patient
transfer
hospit
dedic
sar
manag
pulmonari
tb
diagnos
posit
acidfast
bacilli
smear
sputum
sampl
patient
known
case
pulmonari
tb
becam
infect
sarscov
contact
patient
hospit
sar
patient
sputum
smearneg
acidfast
bacilli
diagnosi
made
basi
previou
exposur
tb
relev
symptom
typic
pulmonari
tb
chest
radiograph
consist
activ
diseas
posit
tuberculin
skin
test
result
find
caviti
regress
chest
radiograph
antitb
treatment
initi
cultur
obtain
isol
comparison
mycobacterium
tuberculosi
strain
patient
confirm
sar
base
amplif
sarscov
rna
revers
transcriptasepolymeras
chain
reaction
rtpcr
sputum
stool
specimen
patient
recov
without
complic
patient
sever
diseas
requir
mechan
ventil
intens
care
unit
recov
cellular
humor
immun
evalu
followup
patient
tlymphocyt
subset
measur
month
diseas
onset
flow
cytometri
use
fluorescein
isothiocyanatelabel
specif
monoclon
antibodi
compar
sar
patient
n
patient
tb
lower
mean
cell
vs
respect
p
lower
mean
cell
vs
respect
p
sarscov
immunoglobulin
g
igg
antibodi
titer
measur
enzymelink
immunosorb
assay
kit
huada
compani
beij
china
month
diseas
onset
titer
measur
tb
patient
month
l
compar
sar
patient
whose
antibodi
remain
detect
throughout
followup
tb
patient
patient
undetect
antibodi
titer
month
respect
patient
antibodi
titer
detect
unusu
low
patient
prolong
viral
excret
stool
sputum
median
rang
durat
viru
excret
stool
sputa
entir
measur
cohort
n
day
respect
day
patient
day
patient
viral
excret
data
could
obtain
patient
sequenti
specimen
detect
unavail
tb
sar
patient
report
rare
occas
cohort
patient
singapor
diagnos
patient
recoveri
sar
patient
studi
tb
develop
patient
acquir
sar
like
result
reactiv
past
infect
new
infect
tuberculosi
temporarili
immunosuppress
sar
corticoid
therapi
phenomena
describ
viral
infect
measl
hiv
contrast
patient
known
tb
patient
acquir
sar
exposur
sar
patient
hospit
ward
diseas
known
transient
immunosuppress
combin
effect
result
pronounc
cell
decreas
coinfect
sar
patient
other
immunosuppress
also
result
poorer
igg
antibodi
respons
coinfect
sar
patient
other
delay
viral
clearanc
shown
longer
viral
excret
sputum
stool
viral
excret
could
prolong
coinfect
patient
viru
could
isol
rtpcrposit
specimen
collect
week
ill
suggest
excret
virus
longer
infecti
case
report
remind
us
import
strict
isol
sar
patient
care
use
steroid
case
manag
possibl
coinfect
tb
sar
patient
incomplet
recoveri
editor
epidemiolog
tetanu
unit
kingdom
chang
cluster
case
inject
drug
user
idu
occur
incid
tetanu
low
unit
kingdom
occasion
case
predominantli
unvaccin
elderli
person
situat
contrast
unit
state
inject
drug
use
commonli
report
among
person
tetanu
investig
uk
cluster
identifi
sourc
infect
opportun
prevent
ascertain
case
statutori
nonstatutori
report
health
protect
agenc
collect
addit
inform
idu
report
case
tetanu
sinc
januari
adapt
exist
enhanc
tetanu
surveil
case
defin
mildtomoder
trismu
least
follow
spastic
dysphagia
respiratori
embarrass
spasm
autonom
dysfunct
person
inject
drug
month
symptom
onset
twentyf
case
report
juli
septemb
figur
thirteen
women
median
age
male
femal
patient
year
age
respect
rang
p
twenti
patient
white
chines
inform
miss
none
report
travel
oversea
becom
sick
seventeen
patient
inform
report
inject
heroin
intramuscularli
subcutan
pop
miss
vein
patient
came
hospit
sever
gener
tetanu
inject
site
infect
common
two
patient
die
case
fatal
survivor
mild
diseas
requir
intens
treatment
median
day
rang
case
complet
inform
tetanu
immun
statu
avail
casepati
base
medic
record
patient
parent
recal
indic
patient
sever
diseas
receiv
dose
necessari
complet
coverag
nine
patient
never
vaccin
twelv
patient
test
tetanu
immun
admiss
standard
indirect
enzymelink
immunosorb
assay
antibodi
level
lower
cutoff
valu
protect
iuml
one
patient
sever
diseas
level
cutoff
valu
patient
mild
diseas
protect
antibodi
level
clostridium
tetani
isol
patient
tetanu
toxin
detect
serum
also
anoth
patient
anaerob
includ
c
novyi
c
histolyticum
c
perfringen
